C-Rad AB (publ) (CRAD-B.ST)
SEK 29.9
(-0.17%)
SEK 29.9
(-0.17%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 64.09 Million SEK | 60.21% |
| 2022 | 40 Million SEK | 132.31% |
| 2021 | 17.22 Million SEK | -32.99% |
| 2020 | 25.7 Million SEK | 71.9% |
| 2019 | 14.95 Million SEK | 28.2% |
| 2018 | 11.66 Million SEK | -41.98% |
| 2017 | 20.1 Million SEK | 216.04% |
| 2016 | 6.36 Million SEK | -38.5% |
| 2015 | 10.34 Million SEK | 28.75% |
| 2014 | 8.03 Million SEK | 95.65% |
| 2013 | 4.1 Million SEK | 30.78% |
| 2012 | 3.13 Million SEK | -22.12% |
| 2011 | 4.03 Million SEK | 62.03% |
| 2010 | 2.48 Million SEK | 8.5% |
| 2009 | 2.29 Million SEK | 92.03% |
| 2008 | 1.19 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 57.1 Million SEK | 0.71% |
| 2024 Q2 | 56.7 Million SEK | 1.25% |
| 2024 Q1 | 56 Million SEK | -12.64% |
| 2023 Q4 | 64.09 Million SEK | 18.92% |
| 2023 Q3 | 53.9 Million SEK | 9.55% |
| 2023 Q2 | 49.2 Million SEK | 5.35% |
| 2023 Q1 | 46.7 Million SEK | 16.72% |
| 2023 FY | 64.09 Million SEK | 60.21% |
| 2022 Q3 | 33.5 Million SEK | 12.79% |
| 2022 Q1 | 25.9 Million SEK | 50.39% |
| 2022 FY | 40 Million SEK | 132.31% |
| 2022 Q2 | 29.7 Million SEK | 14.67% |
| 2022 Q4 | 40 Million SEK | 19.43% |
| 2021 Q4 | 17.22 Million SEK | 49.76% |
| 2021 FY | 17.22 Million SEK | -32.99% |
| 2021 Q2 | 16.6 Million SEK | -21.33% |
| 2021 Q3 | 11.5 Million SEK | -30.72% |
| 2021 Q1 | 21.1 Million SEK | -17.91% |
| 2020 FY | 25.7 Million SEK | 71.9% |
| 2020 Q1 | 16.7 Million SEK | 11.69% |
| 2020 Q2 | 17.8 Million SEK | 6.59% |
| 2020 Q3 | 20.7 Million SEK | 16.29% |
| 2020 Q4 | 25.7 Million SEK | 24.16% |
| 2019 Q4 | 14.95 Million SEK | 62.52% |
| 2019 Q2 | 9.2 Million SEK | -8.91% |
| 2019 Q1 | 10.1 Million SEK | -13.4% |
| 2019 FY | 14.95 Million SEK | 28.2% |
| 2019 Q3 | 9.2 Million SEK | 0.0% |
| 2018 Q3 | 11.7 Million SEK | 3.54% |
| 2018 Q2 | 11.3 Million SEK | -41.45% |
| 2018 Q1 | 19.3 Million SEK | -3.98% |
| 2018 FY | 11.66 Million SEK | -41.98% |
| 2018 Q4 | 11.66 Million SEK | -0.32% |
| 2017 Q1 | 5.85 Million SEK | -7.96% |
| 2017 Q4 | 20.1 Million SEK | 195.6% |
| 2017 FY | 20.1 Million SEK | 216.04% |
| 2017 Q3 | 6.8 Million SEK | 9.93% |
| 2017 Q2 | 6.18 Million SEK | 5.67% |
| 2016 FY | 6.36 Million SEK | -38.5% |
| 2016 Q4 | 6.36 Million SEK | -23.1% |
| 2016 Q2 | 10.63 Million SEK | 20.75% |
| 2016 Q1 | 8.8 Million SEK | -14.84% |
| 2016 Q3 | 8.27 Million SEK | -22.22% |
| 2015 Q1 | 10.22 Million SEK | 27.29% |
| 2015 FY | 10.34 Million SEK | 28.75% |
| 2015 Q4 | 10.34 Million SEK | -2.92% |
| 2015 Q3 | 10.65 Million SEK | -14.56% |
| 2015 Q2 | 12.46 Million SEK | 21.95% |
| 2014 Q3 | 8.81 Million SEK | 101.26% |
| 2014 Q4 | 8.03 Million SEK | -8.93% |
| 2014 Q1 | 6.38 Million SEK | 55.55% |
| 2014 FY | 8.03 Million SEK | 95.65% |
| 2014 Q2 | 4.38 Million SEK | -31.37% |
| 2013 Q1 | 4.08 Million SEK | 30.1% |
| 2013 Q4 | 4.1 Million SEK | -27.68% |
| 2013 FY | 4.1 Million SEK | 30.78% |
| 2013 Q2 | 5.99 Million SEK | 46.79% |
| 2013 Q3 | 5.67 Million SEK | -5.3% |
| 2012 Q4 | 3.13 Million SEK | -39.45% |
| 2012 Q3 | 5.18 Million SEK | 10.34% |
| 2012 FY | 3.13 Million SEK | -22.12% |
| 2012 Q1 | 3.52 Million SEK | -12.45% |
| 2012 Q2 | 4.69 Million SEK | 33.13% |
| 2011 Q4 | 4.03 Million SEK | 8.09% |
| 2011 FY | 4.03 Million SEK | 62.03% |
| 2011 Q1 | 2.11 Million SEK | -15.02% |
| 2011 Q2 | 2.77 Million SEK | 31.22% |
| 2011 Q3 | 3.72 Million SEK | 34.43% |
| 2010 FY | 2.48 Million SEK | 8.5% |
| 2010 Q3 | 1.4 Million SEK | -30.63% |
| 2010 Q1 | 2.23 Million SEK | -2.43% |
| 2010 Q2 | 2.03 Million SEK | -9.21% |
| 2010 Q4 | 2.48 Million SEK | 76.56% |
| 2009 Q4 | 2.29 Million SEK | 1248.71% |
| 2009 Q2 | 718 Thousand SEK | -29.88% |
| 2009 Q1 | 1.02 Million SEK | -14.24% |
| 2009 FY | 2.29 Million SEK | 92.03% |
| 2009 Q3 | 170 Thousand SEK | -76.32% |
| 2008 FY | 1.19 Million SEK | 0.0% |
| 2008 Q4 | 1.19 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | -837.272% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 47.112% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 47.112% |
| Arcoma AB | 28.02 Million SEK | -128.708% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | -116.218% |
| BICO Group AB (publ) | 493.1 Million SEK | 87.001% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | -2.724% |
| CellaVision AB (publ) | 126.03 Million SEK | 49.142% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -948.242% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -3519.585% |
| Duearity AB (publ) | 4.15 Million SEK | -1441.236% |
| Dignitana AB (publ) | 7.41 Million SEK | -764.697% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -1632.432% |
| Getinge AB (publ) | 6.41 Billion SEK | 99.001% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 3907.836% |
| Iconovo AB (publ) | -4.86 Million SEK | 1418.387% |
| Integrum AB (publ) | 22.36 Million SEK | -186.648% |
| Luxbright AB (publ) | 8000.00 SEK | -801149.988% |
| Mentice AB (publ) | 14.1 Million SEK | -354.481% |
| OssDsign AB (publ) | 4.3 Million SEK | -1389.312% |
| Paxman AB (publ) | 19.99 Million SEK | -220.516% |
| Promimic AB (publ) | 330 Thousand SEK | -19324.242% |
| Qlife Holding AB (publ) | 7.29 Million SEK | -779.046% |
| SciBase Holding AB (publ) | 11.91 Million SEK | -437.797% |
| ScandiDos AB (publ) | 22.69 Million SEK | -182.503% |
| Sectra AB (publ) | 36.59 Million SEK | -75.184% |
| Sedana Medical AB (publ) | 42.97 Million SEK | -49.156% |
| Senzime AB (publ) | 20.34 Million SEK | -215.143% |
| SpectraCure AB (publ) | 1.00 SEK | -6409999800.0% |
| Stille AB | 66.55 Million SEK | 3.686% |
| Vitrolife AB (publ) | 413 Million SEK | 84.479% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 54.733% |